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Tissue culture techniques are inadequate to diagnose some viral infections. Thus, solid-phase
immunoassays have been developed for the direct detection of viral antigens in clinical
specimens. While radioimmunoassays (RIA) have attained widespread use, solid-phase enzyme-
linked immunosorbent assays (ELISA) offer a number of advantages over RIA systems.
ELISAs can be established with approximately the same sensitivity as radioimmunoassays
without utilizing unstable, gamma-emitting isotopes.
However, before ELISA systems can obtain widespread usage, a number ofaspects ofthe test
must be optimized. These include the preparation and use of reagents, the nature of the solid
phase, the choice of enzyme, and the enzyme-antibody conjugation method. With the solving of
these problems, ELISA should attain widespread usage for rapid diagnosis ofa large number of
infectious agents.
In the past, infectious diseases have been diagnosed by the cultivation Qf an
infecting agent from a body site. The development of efficient cultivation techniques
has allowed reliable detection ofa large number ofbacterial, viral, and fungal agents.
However, for some infectious diseases, standard cultivation techniques have not
yielded an etiologic agent. For example, while it had been established by epidemio-
logical means that hepatitis can be transmitted by a number of routes, tissue culture
cultivation ofspecimens which were known to be infectious failed to yield a causative
agent [1,2,3]. Similarly, while it had been shown that gastroenteritis in infants and
young children is caused by a non-bacterial infectious agent, extensive attempts at
cultivating such agents have proven fruitless [4,5]. In addition, cultivation techniques
generally require the lapse of a substantial period of time before a diagnosis can be
made. In the case of many viral and fungal agents, diagnosis based on the cultivation
of an agent often cannot be made with sufficient rapidity to be of use in the
management of an acute illness.
Because ofthese shortcomings, there has been a great deal ofinterest in developing
means of detecting infectious agents without relying on cultivation. One method of
detecting viral agents is immune electron microscopy [6]. Two agents which cause
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All rights of reproduction in any form reserved.hepatitis in humans, hepatitis A and B [3,7], and two agents which cause diarrhea,
rotavirus and Norwalk virus [9,10], were first investigated using electron microscopic
techniques, and electron microscopy was used to elucidate the basic epidemiology of
these agents. However, while electron microscopy represents an important advance in
the understanding of viral infections, the need for sophisticated technology and
interpretation has limited the general usefulness of this technique. Thus there has
been great interest in other means of detecting and identifying non-cultivable
antigens. While a number of such techniques have been developed, the one that has
attained the most widespread usage for detection of hepatitis A and B antigens has
been radioimmunoassay (RIA). The reasons for the success of RIA include the
sensitivity and objectivity of the assay and the fact that a large number of specimens
can be tested at one time. However, radioirmmunoassays, which rely on the emission
of gamma-radiation by an isotope-bound immunoreactant, have a number of
disadvantages. For example, the fact that radioactive isotopes have an inherent rate
ofdecay means that the radio-labelled reagents will lose their activity over time. Thus
repeated relabelling, retesting, and restandardization is required. Also, RIA systems
subject the users to a potential radiation hazard. Finally, expensive equipment is
needed to measure the radiation, thus restricting RIAs to central laboratories [10].
For these reasons there has been agreat deal of interest in developing assay systems
which would retain the advantages of RIA but avoid some of its inherent problems.
The method which has come closest to achieving this goal has been the technique of
enzyme immunoassay, also known asenzyme-linked immunosorbent assay (ELISA).
ELISA is similar to RIA except that an enzyme is used as the immunoglobulin
marker in place of a radioactive isotope. Since a single molecule ofenzyme can react
with a large number of substrate molecules, a very small amount of enzyme-labelled
immunoglobulin can react with substrate to provide a visibly colored reaction. Thus
expensive detection equipment is not needed. Also, enzyme-antibody conjugates can
be prepared which have negligible loss of activity after long periods of storage, thus
obviating the need for constant relabelling and retesting of reagents [9-12].
ELISA systems can be devised to measure either antigen or antibody by means ofa
number of system designs. In the case of the detection of an infectious agent, it is
generally more convenient to label the antibody than the antigen, since the latter
might not be available in purified form [36]. Thus a binding or sandwich assay is
commonly used for the detection ofantigen in bodily fluids. The simplest such system
is a direct or one-antibody sandwich, shown in Fig. 1. In this system, which is
analogous to the RIA widely used for the detection of hepatitis B antigen [13], an
antibody, referred to as the capture antibody, is used to coat a solid phase. After a
suitable incubation period, the unbound antibody is washed off and the test specimen
is added. After another incubation period, the excess specimen is washed off and an
aliquot ofenzyme-labelled antibody is added. This will bind to any antigen bound to
the capture antibody on the solid phase. After washing off ofthe unbound enzyme-
labelled antibody, substrate is added. Enzyme bound to the solid phase by the
previous steps will convert the substrate to a visible form which can be seen by the
naked eye or measured in a spectrophotometer. This system has the advantage of
requiring only a single antibody. Direct, single antibody ELISA systems have been
devised for the detection of hepatitis A [14], hepatitis B (surface antigen and "e"
antigen) [15,16], and human rotavirus [17].
One disadvantage ofthissingleantibodyapproach is that it requires the laboratory
to have an enzyme-labelled reagent for each antigen to be tested. It would be more
convenient to require onlysingle labelled reagent, since this could be made commer-
86 ROBERT H. YOLKENDIAGNOSIS BY ELISA
FIG. 1. Direct Antigen Assay. (Drawing by Nancy Lou Gahan. Reprinted courtesy of Hospital
Practice, HP Publishing Co. Inc.)
cially available. This can be accomplished by the use of an indirect ELISA, as
outlined in Fig. 2. In this case, an unlabelled, second antibody is utilized and is
quantitated by the use of an enzyme-labelled anti-immunoglobulin. This method is
thus analogous to indirect immunofluorescence [18]. As in that method, a single
labelled antiglobulin can be used in any test system as long as the second antibody is
of the same animal species. For example, we have found enzyme-labelled anti-guinea
pig IgG to be an excellent reagent in any ELISA in whichguinea pig antibody is used
as the second antibody [19-22]. In addition, the indirect ELISA often displays
increased sensitivity over the analogous direct system. Since a single molecule of
unlabelled antibody is able to react with a number ofanti-globulin molecules, there is
an increase in the number of enzyme molecules bound per molecule ofantigen with a
resulting increase in sensitivity [36]. Thus we have been able to develop an ELISA
system capable of measuring 1 pg ofcholera toxin[22]. However, the indirect ELISA
system does have an inherent disadvantage, namely that reagents prepared in two
different animal species must be used to prevent the non-specific binding of the anti-
FIG. 2. Indirect Antigen Assay. (Drawing by Nancy Lou Gahan. Reprinted courtesy of Hospital
Practice, HP Publishing Co. Inc.)
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immunoglobulin to the solid phase. Thus indirect ELISA systems cannot be
established for antigens such as hepatitis A, where only reagents obtained from
humans and other primates are available [14].
There are a number of variables which enter into the development of a successful
ELISA system. These include reagents, solid-phase enzyme conjugation methods,
and non-specific activity. All of these factors must be optimized before ELISA
technology can attain widespread usage.
REAGENTS
A basic requirement for a successful ELISA system is antibody specific for the
antigen being measured. Antisera which are adequate for less sensitive tests such as
complement fixation are often not specific enough for ELISA in that cross-reactions
will be noted with other viruses [12]. In general, antisera used in direct ELISA
systems must be prepared by the immunization of animals with highly purified
antigen [36]. Fortunately, the sensitivity of ELISA is such that once a satisfactory
antiserum is prepared, it can be used at extremely high dilutions, so that the reagent
can be conserved. For example, our goat antisera for human rotavirus can be used at
1:100,000, allowing for 1,000,000 tests to be performed from 1 ml of antiserum [20].
In the case of the indirect tests, it is preferable that one of the two antisera used be
made from highly purified reagents. The second antiserum can be less specific. For
example, high titered human infection serum can be utilized. In our experience, it is
preferable that the more specific reagent be used to coat the solid phase and the
infection serum be used as the second antibody (R. Yolken et al., unpublished
studies).
In most cases, whole serum can be used for the capture and unlabelled second
antibody. Optimal dilutions are established by checkerboard titration [11]. In
general, most hyperimmune sera can be utilized at dilutions of 1:4,000 to 1:100,000,
while infection sera can be used at dilutions of 1:400 to 1:2,000. However, in some
cases non-specific reactions due to the lgM fraction of the reagents [37] necessitate
the use of the IgG fractions of the sera. The IgGfraction is prepared by precipitation
of the serum in ammonium sulfate and, after dialysis in 0.01 M phosphate buffer,
removal of the IgM fraction by passage through a positively charged ion exchange
column [23]. As in the case of whole serum, the optimal concentration for the assay
should be determined by checkerboard titration. In most cases this optimal concen-
tration of IgG will be between 0.1 ug/ml and 1 ug/ml.
ENZYME
The basic requirements for a suitable enzyme for ELISA systems are that the
enzyme be active when conjugated to anantibody molecule and that the conjugate be
stable during storage. Two enzymes which have attained widespread usage are
peroxidase and alkaline phosphatase [24-25]. Peroxidase has the advantage ofbeing
relatively inexpensive and having a number ofsubstrate systems which produce color
easily visualized by the naked eye. However, most of the proton receptors utilized
precipitate after reaction, thus decreasing the sensitivity of the assay [38]. An
additional disadvantage of peroxidase is that it is inactivated by bacteriostatic agents
such as sodium azide, thus shortening its effective shelflife. Alkaline phosphatase, on
the other hand, is stable in sodium azide and has a number of naturally occurring
substrates. However, alkaline phosphatase ofspecificactivity highenough to be used
must be obtained from mammalian tissue such as calf intestine. This source is
expensive and the supply is often limited. Other enzymes which have been used
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include glucose oxidase, , galactosidase, and penicillinase [26,27,38]. All are widely
available and have a number of usable substrates. However, their utility in ELISA
systems remains to be determined.
SOLID PHASE
All immunoassays which utilize labelled reactants require a separation step in
which labelled reactants not bound in the antigen-antibody reactions are removed
from the reaction milieu [12]. If unreacted, labelled reactants are not separated from
those involved in the specific reaction, non-specific activity will result. While
differential precipitation and centrifugation have been used to achieve this separation
[28], most of these methods are not practical for wide-scale usage. On the other hand,
effective separation can be achieved by binding the reactants to a solid phase and
washing off the unreacted labelled material [36]. A number ofsolid phases have been
utilized, including test tubes, beads, filter papers, discs, resins, and microtitration
plates of varying makeup [11,12,27,29,30,31]. While there are theoretical advantages
in establishing a covalent bond between the capture antibody and the solid phase by
means ofa bifunctional reagent such as cyanogen bromide or glutaraldehyde, the fact
that immunoglobulin molecules will bind to a number of plastics by means of
hydrogen bonds greatly simplifies the process of attaching antibody to the solid
phase. In most cases, simply placing a solution of serum or immunoglobulin diluted
to 1-10 ug/ ml in an appropriate buffer (such as 0.06 M carbonate pH 9.6) will result
in a large percentage of binding over a four-hour period at 370C or overnight at
40C [36]. Non-specific adherence of the other immunoreactants is minimized by
their dilution in a nonionic detergent such as Tween 20 and an excess of a non-
immunogenic protein such as fetal calf serum or gelatin. In addition, background
reactivity due to non-specific adherence is minimized by careful aspiration and
washing with an excess of detergent-containing fluid [11,32]. In our hands, we have
found that flexible 96 well, polyvinyl microtiter plates provide excellent binding of
the capture antibody without significant binding of the other reactants. Aspiration of
well contents is easily accomplished by means of a manifold which is capable of
aspirating all 96 wells at once and washing by means of a similar manifold device
[32]. Addition of reagents is accomplished by any of a number of multi-channel
pipetting devices. The resulting color reaction can be read by the naked eye or by
means of a spectrophotometer. Photometric determinations are expedited by use of a
colorimeter capable of determining optical density directly in the wells of the
microtiter plate [33]. The only problem encountered with these plates has been higher
readings in the wells on the outer rows of the plates and an occasional erratic reading
in a single well anywhere on the plate. These problems can be overcome by the
avoidance of the outer rows and the running of specimens in duplicate. Even with
these restrictions, 30 specimens can be run on one microtiter plate and, by using semi-
automated washing and reading equipment, up to 6 plates can be run in a single day
by one worker [32]. While microtiter plates of hard plastic can be used, we have
found that they tend to bind less ofthe captureantibody, necessitating application of
this antibody at a higher concentration.
One disadvantage in the use of microtiter plates is that there is a relatively small
surface area available for binding. This necessitates relatively long incubation times,
especially for the addition of the unknown antigen. For example, overnight incuba-
tion is required for maximal sensitivity in the rotavirus ELISA assay. It would thus
be advantageous to utilize a solid phase with greater surface area when more rapid
test results are required. This might be accomplished by the use of filter papers or
89other porous solid-phase systems [29]. These solid-phase systems are currently under
investigation in our laboratory.
NON-SPECIFIC REACTIONS
Non-specific ELISA reactions can occur by a variety of mechanisms. Non-specific
binding of immunoreactants to a solid phase, which has been discussed above, can be
minimized by proper choice of the solid-phase material and careful washing tech-
nique. When antibodies are prepared using crude antigen, the resulting ELISA assay
might yield positive results when antigens other than the target antigen are present in
the test specimen. This problem is alleviated by absorbing the antibody with the
cross-reacting antigen or, preferably, purifying theantibody by affinity chromatogra-
phy [38]. The use of the newly developing technology of monoclonal antibodies
would also eliminate this problem. Finally, some specimens can yield false positive
results due to non-specific antiglobulin activity directed against the other immuno-
reactants. This non-specific activity can be eliminated or markedly reduced by the
addition of normal animal serum to the reaction mixture [19]. Also, since the
antiglobulin is often a rheumatoid factor of the IgM subclass, its activity can be
reduced by the addition of a mild reducing agent such as 20 percent N-acetyl-cysteine
[37].
Because of these non-specific reactions, it is advisable to confirm each positive
reaction with a second test. This can be accomplished by means of a blocking test in
which the antigen is incubated with immune serum from a source independent ofthe
immunoreactants used in other parts of the assay. Such serum should reduceactivity
due to the antigen while a non-immune serum should not reduce specificactivity [17].
A simpler confirmatory test consists of testing each specimen in wells coated with
non-immune serum from the same animal that was used to prepare the capture
antibody. A specimen containing specific antigen activity will yield color only in the
well coated with the capture antibody, while a specimen containing antiglobulin
activity will react in the well coated with the non-immune serum in addition to the
well coated with the specific antiserum.
CONJUGATION METHODS
All enzyme immunoassays utilize an enzyme bound to either an antigen or, more
commonly, an antibody molecule. Successful coupling involves the maintenance of
both enzyme activity and immune activity following the conjugation reaction. Most
coupling procedures utilize a bifunctional reagent such as glutaraldehyde [24-25] or
sodium m-periodate [34]. In the case of glutaraldehyde, coupling probably occurs by
the reaction of thealdehyde group with theepsilon-amino groups ofthe antibody and
the enzyme. This coupling can be most efficiently achieved in a two-step method
which involves first activating the enzyme with glutaraldehyde, removing the excess
coupling agent by column chromatography, and then adding the immunoreactant
[24]. While this method has a higher yield because of decreased self-coupling, it is
often more convenient to use a one-step method, which involves the simple mixing of
enzyme, immunoreactant, and coupling agent with subsequent dialysis of the
reaction mixture to remove excess coupling agent [12]. Ourexperience indicates that
this one-step method will yield adequate conjugates for use in the indirect ELISA
system. However, for the direct system, the two-step method is often the preferable
procedure for conjugation.
An alternate conjugation method involves the use of sodium m-periodate to
conjugate the amino groups of antibody with the active aldehyde groups of the
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polysaccharide portion ofthe enzyme. This method has the advantage ofallowing for
controlled conjugation, thus offering optimal ratios of antibody to enzyme [34].
However, this process is limited to use for enzymes, such as peroxidase, which
contain significant amounts of glycoprotein. Utilizing this enzyme, highly efficient
conjugates have been made with immunoglobulin from a number ofanimal species.
In addition, peroxidase is inexpensive and widely available. However, substrates for
peroxidase are limited and have the disadvantages described above.
In addition to the above methods, other agents such asp-benzoquinone and N, n'-
o-phenylene dimaleimide have been shown to be efficient coupling agents [27,35,39].
However, conjugates made from these agents have not yet received widespread use in
ELISA systems and their efficiency in these systems remains to be determined.
QUANTITATION OF REACTION
The rate of an enzymatic reaction is dependent on a number of factors including
substrate concentration, temperature, and pH [36]. Since the variables can be
difficult to control under laboratory conditions, it is necessary to include in every
quantitative ELISA test a number of control specimens with known quantities of
antigen. When a curve is constructed from the optical density values ofthese control
specimens, accurate quantitation of unknowns can be performed [40]. In the case of
qualitative assays in which the goal is simply to determine the presence or absence of
an antigen in a specimen antigen, uniform sensitivity is ensured when weakly positive
controls with predetermined amounts ofantigen are added and when the positivity of
a specimen is determined by comparison to these controls.
CONCLUSION
When the above variables are controlled, ELISA systems of extreme sensitivity
and reliability can be constructed. The main limitation to the widespread utilization
of ELISA assays is the production and distribution of the suitable reagents. The
availability of such reagents, especially in the form of pre-packaged kits, will allow
the clinician to rapidly diagnose a wide range of bacterial, fungal, and viral
infections. This will not only allow the rational management of infectious disease but
also increase understanding of a large number ofdisease processes. It is hoped that,
in the coming years, the full potential of this simple yet powerful technique will be
utilized.
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